Insider Trading Summary for Iovance Biotherapeutics, Inc. (IOVA): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
20-Feb-24 7:52 PM View:	20-Feb-24 Private Purchase $2.29M	McPeak Merrill A/ Director		Iovance Biotherapeutics, Inc. - IOVA	78% 318.78K to 568.78K	0	0	--	--	Show Txns Hide Txns

20-Feb-24 4:11 PM View:	20-Feb-24 Private Purchase $45.75M	Rothbaum Wayne P. Director		Iovance Biotherapeutics, Inc. - IOVA	22% 23.07M to 28.07M	0	0	--	--	Show Txns Hide Txns

20-Feb-24 4:21 PM View:	20-Feb-24 Private Purchase $292.80K	Dukes Iain D. Director		Iovance Biotherapeutics, Inc. - IOVA	145% 22.0K to 54.0K	0	0	--	--	Show Txns Hide Txns

05-Sep-24 7:54 PM View:	03-Sep-24 Payment of Exercise ($150.53K)	Graf Finckenstein Friedrich Chief Medical Officer		Iovance Biotherapeutics, Inc. - IOVA	92% 30.95K to 59.34K	0	0	--	--	Show Txns Hide Txns

05-Sep-24 7:52 PM View:	03-Sep-24 Payment of Exercise ($129.02K)	Bellemin Jean-Marc Chief Financial Officer		Iovance Biotherapeutics, Inc. - IOVA	65% 17.8K to 29.35K	0	0	--	--	Show Txns Hide Txns

05-Sep-24 7:53 PM View:	03-Sep-24 Payment of Exercise ($148.37K)	Bilinsky Igor Chief Operating Officer		Iovance Biotherapeutics, Inc. - IOVA	100% 27.21K to 54.42K	0	0	--	--	Show Txns Hide Txns

05-Sep-24 7:56 PM View:	03-Sep-24 Payment of Exercise ($264.08K)	Vogt Frederick G Interim CEO & General Counsel Director		Iovance Biotherapeutics, Inc. - IOVA	164% 72.85K to 192.26K	0	0	--	--	Show Txns Hide Txns

Buy:	0	--
Sell:	0	--